$76.91
+2.62 (+3.53%)
Performance
1D
—
1W
—
1M
—
3M
+21.39%
6M
+15.65%
1Y
+139.37%
YTD
+24.59%
Open$74.51
Previous Close$74.29
Day High$78.80
Day Low$74.51
52W High$80.20
52W Low$29.31
Volume—
Avg Volume4.64M
Market Cap9.60B
P/E Ratio—
EPS$-6.53
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$63.59
Above
SMA 200
$49.97
Above
RSI (14)
55.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
27 analysts
Price Target
+3.8% upside
Current
$76.91
$76.91
Target
$79.81
$79.81
$53.35
$79.81 avg
$115.71
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 91.46M | 93.68M | 617.31M |
| Net Income | -815,474,440 | -751,743,312 | 113.32M |
| Profit Margin | -891.6% | -847.0% | 18.4% |
| EBITDA | -751,715,786 | -731,465,734 | 314.99M |
| Free Cash Flow | — | — | 143.60M |
| Rev Growth | -2.4% | -2.4% | +3.9% |
| Debt/Equity | 0.59 | 0.59 | 0.20 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |